CXCL12 and neoplasm: In mouse models of PDAC, the population of CAFs expressing α-SMA exhibit increased activation of Shh signaling that inhibits the production of VEGF, CXCL-12 and IL-8, which affects tumor growth, angiogenesis and immunosuppression [126,127].